Loading…
Relationships with serum parathyroid hormone in old institutionalized subjects
OBJECTIVE and BACKGROUND Old people in residential care are at the highest risk of any group for hip fracture. This may relate to their high prevalence of hyperparathyroidism. There are few data, however, on relationships with serum parathyroid hormone (PTH) in these individuals. This study therefor...
Saved in:
Published in: | Clinical endocrinology (Oxford) 2001-05, Vol.54 (5), p.583-592 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4582-5f6f35432d1bd7dbab8eafbad614530f096a5bdca0f70113d9c30fdd97574f9d3 |
---|---|
cites | cdi_FETCH-LOGICAL-c4582-5f6f35432d1bd7dbab8eafbad614530f096a5bdca0f70113d9c30fdd97574f9d3 |
container_end_page | 592 |
container_issue | 5 |
container_start_page | 583 |
container_title | Clinical endocrinology (Oxford) |
container_volume | 54 |
creator | Stein, M. S. Flicker, L. Scherer, S. C. Paton, L. M. O'Brien, M. L. Walton, S. C. Chick, P. Di Carlantonio, M. Zajac, J. D. Wark, J. D. |
description | OBJECTIVE and BACKGROUND Old people in residential care are at the highest risk of any group for hip fracture. This may relate to their high prevalence of hyperparathyroidism. There are few data, however, on relationships with serum parathyroid hormone (PTH) in these individuals. This study therefore examined complex associations with serum PTH in nursing home and hostel residents.
DESIGN Cross‐sectional analysis.
PATIENTS One hundred and forty‐three nursing home and hostel residents of median age 84 years.
MEASUREMENTS Serum PTH, 25‐hydroxyvitamin D (25OHD), 1,25‐dihydroxyvitamin D (1,25‐(OH)2D), plasma creatinine, phosphate, calcium, albumin, Bsm‐1 vitamin D receptor genotype, age, weight and use of frusemide or thiazide.
RESULTS The statistical models determined accounted for half the interindividual variation in serum PTH. Heavier weight was associated with both the prevalence of secondary hyperparathyroidism and the serum concentration of PTH. Novel interactions with serum PTH were identified between: weight and 25OHD; 25OHD and phosphate; and phosphate and thiazide diuretic use. Plasma phosphate was associated with PTH independently of calcium and 1,25‐(OH)2D. There was no independent association between PTH and nuclear vitamin D receptor genotype.
CONCLUSIONS Heavier weight is associated with both the prevalence and severity of secondary hyperparathyroidism and consistent with animal models of secondary hyperparathyroidism, phos‐phate may relate to serum PTH independently of 1,25‐(OH)2D or calcium. |
doi_str_mv | 10.1046/j.1365-2265.2001.01182.x |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70878997</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70878997</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4582-5f6f35432d1bd7dbab8eafbad614530f096a5bdca0f70113d9c30fdd97574f9d3</originalsourceid><addsrcrecordid>eNqNkUuP0zAURi0EYsrAX0ARSOwSruP4tWCBqmFmxFAEArG0nNhWHfIodqJp-fXj0KpIrFhdyz7nXvszQhmGAkPF3rYFJozmZcloUQLgAjAWZbF_hFbng8doBQQgB8aqC_QsxhYAqAD-FF1gTARUQqzQ5qvt9OTHIW79Lmb3ftpm0Ya5z3Y66Gl7CKM32XYM_TjYzA_Z2JlU4uSnedF0539bk8W5bm0zxefoidNdtC9O9RJ9_3D1bX2T332-vl2_v8ubiooyp445QitSGlwbbmpdC6tdrQ3DFSXgQDJNa9NocDw9jRjZpF1jJKe8ctKQS_Tm2HcXxl-zjZPqfWxs1-nBjnNUHAQXUvIEvvoHbMc5pGtHhWViSiZkgsQRasIYY7BO7YLvdTgoDGoJXLVqyVUtuaolcPUncLVP6stT_7nurfkrnhJOwOsToGOjOxf00Ph45iQv0_8k6t2RuvedPfz3eLW-2iyr5OdH38fJ7s--Dj8V44RT9WNzrT7i9c3mk2DqC3kA8USroQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>198782689</pqid></control><display><type>article</type><title>Relationships with serum parathyroid hormone in old institutionalized subjects</title><source>Wiley</source><creator>Stein, M. S. ; Flicker, L. ; Scherer, S. C. ; Paton, L. M. ; O'Brien, M. L. ; Walton, S. C. ; Chick, P. ; Di Carlantonio, M. ; Zajac, J. D. ; Wark, J. D.</creator><creatorcontrib>Stein, M. S. ; Flicker, L. ; Scherer, S. C. ; Paton, L. M. ; O'Brien, M. L. ; Walton, S. C. ; Chick, P. ; Di Carlantonio, M. ; Zajac, J. D. ; Wark, J. D.</creatorcontrib><description>OBJECTIVE and BACKGROUND Old people in residential care are at the highest risk of any group for hip fracture. This may relate to their high prevalence of hyperparathyroidism. There are few data, however, on relationships with serum parathyroid hormone (PTH) in these individuals. This study therefore examined complex associations with serum PTH in nursing home and hostel residents.
DESIGN Cross‐sectional analysis.
PATIENTS One hundred and forty‐three nursing home and hostel residents of median age 84 years.
MEASUREMENTS Serum PTH, 25‐hydroxyvitamin D (25OHD), 1,25‐dihydroxyvitamin D (1,25‐(OH)2D), plasma creatinine, phosphate, calcium, albumin, Bsm‐1 vitamin D receptor genotype, age, weight and use of frusemide or thiazide.
RESULTS The statistical models determined accounted for half the interindividual variation in serum PTH. Heavier weight was associated with both the prevalence of secondary hyperparathyroidism and the serum concentration of PTH. Novel interactions with serum PTH were identified between: weight and 25OHD; 25OHD and phosphate; and phosphate and thiazide diuretic use. Plasma phosphate was associated with PTH independently of calcium and 1,25‐(OH)2D. There was no independent association between PTH and nuclear vitamin D receptor genotype.
CONCLUSIONS Heavier weight is associated with both the prevalence and severity of secondary hyperparathyroidism and consistent with animal models of secondary hyperparathyroidism, phos‐phate may relate to serum PTH independently of 1,25‐(OH)2D or calcium.</description><identifier>ISSN: 0300-0664</identifier><identifier>EISSN: 1365-2265</identifier><identifier>DOI: 10.1046/j.1365-2265.2001.01182.x</identifier><identifier>PMID: 11380488</identifier><identifier>CODEN: CLECAP</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Aged ; Aged, 80 and over ; Benzothiadiazines ; Biological and medical sciences ; Body Weight ; Cross-Sectional Studies ; Diuretics ; Endocrinopathies ; Female ; Furosemide - therapeutic use ; Genotype ; Hip Fractures - etiology ; Homes for the Aged ; Humans ; Hydroxycholecalciferols - blood ; Hyperparathyroidism, Secondary - complications ; Hyperparathyroidism, Secondary - diagnosis ; Institutionalization ; Linear Models ; Male ; Medical sciences ; Non tumoral diseases. Target tissue resistance. Benign neoplasms ; Nursing Homes ; Parathyroid Hormone - blood ; Parathyroids. Parafollicular cells. Cholecalciferol. Phosphocalcic homeostasis (diseases) ; Phosphates - blood ; Receptors, Calcitriol - genetics ; Risk Factors ; Sodium Chloride Symporter Inhibitors - therapeutic use ; Tropical medicine</subject><ispartof>Clinical endocrinology (Oxford), 2001-05, Vol.54 (5), p.583-592</ispartof><rights>2001 INIST-CNRS</rights><rights>Copyright Blackwell Scientific Publications Ltd. May 2001</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4582-5f6f35432d1bd7dbab8eafbad614530f096a5bdca0f70113d9c30fdd97574f9d3</citedby><cites>FETCH-LOGICAL-c4582-5f6f35432d1bd7dbab8eafbad614530f096a5bdca0f70113d9c30fdd97574f9d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=972664$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11380488$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stein, M. S.</creatorcontrib><creatorcontrib>Flicker, L.</creatorcontrib><creatorcontrib>Scherer, S. C.</creatorcontrib><creatorcontrib>Paton, L. M.</creatorcontrib><creatorcontrib>O'Brien, M. L.</creatorcontrib><creatorcontrib>Walton, S. C.</creatorcontrib><creatorcontrib>Chick, P.</creatorcontrib><creatorcontrib>Di Carlantonio, M.</creatorcontrib><creatorcontrib>Zajac, J. D.</creatorcontrib><creatorcontrib>Wark, J. D.</creatorcontrib><title>Relationships with serum parathyroid hormone in old institutionalized subjects</title><title>Clinical endocrinology (Oxford)</title><addtitle>Clin Endocrinol (Oxf)</addtitle><description>OBJECTIVE and BACKGROUND Old people in residential care are at the highest risk of any group for hip fracture. This may relate to their high prevalence of hyperparathyroidism. There are few data, however, on relationships with serum parathyroid hormone (PTH) in these individuals. This study therefore examined complex associations with serum PTH in nursing home and hostel residents.
DESIGN Cross‐sectional analysis.
PATIENTS One hundred and forty‐three nursing home and hostel residents of median age 84 years.
MEASUREMENTS Serum PTH, 25‐hydroxyvitamin D (25OHD), 1,25‐dihydroxyvitamin D (1,25‐(OH)2D), plasma creatinine, phosphate, calcium, albumin, Bsm‐1 vitamin D receptor genotype, age, weight and use of frusemide or thiazide.
RESULTS The statistical models determined accounted for half the interindividual variation in serum PTH. Heavier weight was associated with both the prevalence of secondary hyperparathyroidism and the serum concentration of PTH. Novel interactions with serum PTH were identified between: weight and 25OHD; 25OHD and phosphate; and phosphate and thiazide diuretic use. Plasma phosphate was associated with PTH independently of calcium and 1,25‐(OH)2D. There was no independent association between PTH and nuclear vitamin D receptor genotype.
CONCLUSIONS Heavier weight is associated with both the prevalence and severity of secondary hyperparathyroidism and consistent with animal models of secondary hyperparathyroidism, phos‐phate may relate to serum PTH independently of 1,25‐(OH)2D or calcium.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Benzothiadiazines</subject><subject>Biological and medical sciences</subject><subject>Body Weight</subject><subject>Cross-Sectional Studies</subject><subject>Diuretics</subject><subject>Endocrinopathies</subject><subject>Female</subject><subject>Furosemide - therapeutic use</subject><subject>Genotype</subject><subject>Hip Fractures - etiology</subject><subject>Homes for the Aged</subject><subject>Humans</subject><subject>Hydroxycholecalciferols - blood</subject><subject>Hyperparathyroidism, Secondary - complications</subject><subject>Hyperparathyroidism, Secondary - diagnosis</subject><subject>Institutionalization</subject><subject>Linear Models</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Non tumoral diseases. Target tissue resistance. Benign neoplasms</subject><subject>Nursing Homes</subject><subject>Parathyroid Hormone - blood</subject><subject>Parathyroids. Parafollicular cells. Cholecalciferol. Phosphocalcic homeostasis (diseases)</subject><subject>Phosphates - blood</subject><subject>Receptors, Calcitriol - genetics</subject><subject>Risk Factors</subject><subject>Sodium Chloride Symporter Inhibitors - therapeutic use</subject><subject>Tropical medicine</subject><issn>0300-0664</issn><issn>1365-2265</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqNkUuP0zAURi0EYsrAX0ARSOwSruP4tWCBqmFmxFAEArG0nNhWHfIodqJp-fXj0KpIrFhdyz7nXvszQhmGAkPF3rYFJozmZcloUQLgAjAWZbF_hFbng8doBQQgB8aqC_QsxhYAqAD-FF1gTARUQqzQ5qvt9OTHIW79Lmb3ftpm0Ya5z3Y66Gl7CKM32XYM_TjYzA_Z2JlU4uSnedF0539bk8W5bm0zxefoidNdtC9O9RJ9_3D1bX2T332-vl2_v8ubiooyp445QitSGlwbbmpdC6tdrQ3DFSXgQDJNa9NocDw9jRjZpF1jJKe8ctKQS_Tm2HcXxl-zjZPqfWxs1-nBjnNUHAQXUvIEvvoHbMc5pGtHhWViSiZkgsQRasIYY7BO7YLvdTgoDGoJXLVqyVUtuaolcPUncLVP6stT_7nurfkrnhJOwOsToGOjOxf00Ph45iQv0_8k6t2RuvedPfz3eLW-2iyr5OdH38fJ7s--Dj8V44RT9WNzrT7i9c3mk2DqC3kA8USroQ</recordid><startdate>200105</startdate><enddate>200105</enddate><creator>Stein, M. S.</creator><creator>Flicker, L.</creator><creator>Scherer, S. C.</creator><creator>Paton, L. M.</creator><creator>O'Brien, M. L.</creator><creator>Walton, S. C.</creator><creator>Chick, P.</creator><creator>Di Carlantonio, M.</creator><creator>Zajac, J. D.</creator><creator>Wark, J. D.</creator><general>Blackwell Science Ltd</general><general>Blackwell</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>200105</creationdate><title>Relationships with serum parathyroid hormone in old institutionalized subjects</title><author>Stein, M. S. ; Flicker, L. ; Scherer, S. C. ; Paton, L. M. ; O'Brien, M. L. ; Walton, S. C. ; Chick, P. ; Di Carlantonio, M. ; Zajac, J. D. ; Wark, J. D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4582-5f6f35432d1bd7dbab8eafbad614530f096a5bdca0f70113d9c30fdd97574f9d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Benzothiadiazines</topic><topic>Biological and medical sciences</topic><topic>Body Weight</topic><topic>Cross-Sectional Studies</topic><topic>Diuretics</topic><topic>Endocrinopathies</topic><topic>Female</topic><topic>Furosemide - therapeutic use</topic><topic>Genotype</topic><topic>Hip Fractures - etiology</topic><topic>Homes for the Aged</topic><topic>Humans</topic><topic>Hydroxycholecalciferols - blood</topic><topic>Hyperparathyroidism, Secondary - complications</topic><topic>Hyperparathyroidism, Secondary - diagnosis</topic><topic>Institutionalization</topic><topic>Linear Models</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Non tumoral diseases. Target tissue resistance. Benign neoplasms</topic><topic>Nursing Homes</topic><topic>Parathyroid Hormone - blood</topic><topic>Parathyroids. Parafollicular cells. Cholecalciferol. Phosphocalcic homeostasis (diseases)</topic><topic>Phosphates - blood</topic><topic>Receptors, Calcitriol - genetics</topic><topic>Risk Factors</topic><topic>Sodium Chloride Symporter Inhibitors - therapeutic use</topic><topic>Tropical medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stein, M. S.</creatorcontrib><creatorcontrib>Flicker, L.</creatorcontrib><creatorcontrib>Scherer, S. C.</creatorcontrib><creatorcontrib>Paton, L. M.</creatorcontrib><creatorcontrib>O'Brien, M. L.</creatorcontrib><creatorcontrib>Walton, S. C.</creatorcontrib><creatorcontrib>Chick, P.</creatorcontrib><creatorcontrib>Di Carlantonio, M.</creatorcontrib><creatorcontrib>Zajac, J. D.</creatorcontrib><creatorcontrib>Wark, J. D.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical endocrinology (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stein, M. S.</au><au>Flicker, L.</au><au>Scherer, S. C.</au><au>Paton, L. M.</au><au>O'Brien, M. L.</au><au>Walton, S. C.</au><au>Chick, P.</au><au>Di Carlantonio, M.</au><au>Zajac, J. D.</au><au>Wark, J. D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Relationships with serum parathyroid hormone in old institutionalized subjects</atitle><jtitle>Clinical endocrinology (Oxford)</jtitle><addtitle>Clin Endocrinol (Oxf)</addtitle><date>2001-05</date><risdate>2001</risdate><volume>54</volume><issue>5</issue><spage>583</spage><epage>592</epage><pages>583-592</pages><issn>0300-0664</issn><eissn>1365-2265</eissn><coden>CLECAP</coden><abstract>OBJECTIVE and BACKGROUND Old people in residential care are at the highest risk of any group for hip fracture. This may relate to their high prevalence of hyperparathyroidism. There are few data, however, on relationships with serum parathyroid hormone (PTH) in these individuals. This study therefore examined complex associations with serum PTH in nursing home and hostel residents.
DESIGN Cross‐sectional analysis.
PATIENTS One hundred and forty‐three nursing home and hostel residents of median age 84 years.
MEASUREMENTS Serum PTH, 25‐hydroxyvitamin D (25OHD), 1,25‐dihydroxyvitamin D (1,25‐(OH)2D), plasma creatinine, phosphate, calcium, albumin, Bsm‐1 vitamin D receptor genotype, age, weight and use of frusemide or thiazide.
RESULTS The statistical models determined accounted for half the interindividual variation in serum PTH. Heavier weight was associated with both the prevalence of secondary hyperparathyroidism and the serum concentration of PTH. Novel interactions with serum PTH were identified between: weight and 25OHD; 25OHD and phosphate; and phosphate and thiazide diuretic use. Plasma phosphate was associated with PTH independently of calcium and 1,25‐(OH)2D. There was no independent association between PTH and nuclear vitamin D receptor genotype.
CONCLUSIONS Heavier weight is associated with both the prevalence and severity of secondary hyperparathyroidism and consistent with animal models of secondary hyperparathyroidism, phos‐phate may relate to serum PTH independently of 1,25‐(OH)2D or calcium.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>11380488</pmid><doi>10.1046/j.1365-2265.2001.01182.x</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0300-0664 |
ispartof | Clinical endocrinology (Oxford), 2001-05, Vol.54 (5), p.583-592 |
issn | 0300-0664 1365-2265 |
language | eng |
recordid | cdi_proquest_miscellaneous_70878997 |
source | Wiley |
subjects | Aged Aged, 80 and over Benzothiadiazines Biological and medical sciences Body Weight Cross-Sectional Studies Diuretics Endocrinopathies Female Furosemide - therapeutic use Genotype Hip Fractures - etiology Homes for the Aged Humans Hydroxycholecalciferols - blood Hyperparathyroidism, Secondary - complications Hyperparathyroidism, Secondary - diagnosis Institutionalization Linear Models Male Medical sciences Non tumoral diseases. Target tissue resistance. Benign neoplasms Nursing Homes Parathyroid Hormone - blood Parathyroids. Parafollicular cells. Cholecalciferol. Phosphocalcic homeostasis (diseases) Phosphates - blood Receptors, Calcitriol - genetics Risk Factors Sodium Chloride Symporter Inhibitors - therapeutic use Tropical medicine |
title | Relationships with serum parathyroid hormone in old institutionalized subjects |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T22%3A34%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Relationships%20with%20serum%20parathyroid%20hormone%20in%20old%20institutionalized%20subjects&rft.jtitle=Clinical%20endocrinology%20(Oxford)&rft.au=Stein,%20M.%20S.&rft.date=2001-05&rft.volume=54&rft.issue=5&rft.spage=583&rft.epage=592&rft.pages=583-592&rft.issn=0300-0664&rft.eissn=1365-2265&rft.coden=CLECAP&rft_id=info:doi/10.1046/j.1365-2265.2001.01182.x&rft_dat=%3Cproquest_cross%3E70878997%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4582-5f6f35432d1bd7dbab8eafbad614530f096a5bdca0f70113d9c30fdd97574f9d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=198782689&rft_id=info:pmid/11380488&rfr_iscdi=true |